SoluFibre
SoluFibre, licence 80098475: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80098475
- Status
- Active licence
- Licence date
- 9 April 2020
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Gomme de Guar partiellement hydrolysée Source : Partially hydrolysed guar gum | 5.0 Grammes | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 9.0 Année(s) | 1.0 packet | 1.0 Tous les jours |
| Adultes | minimum: 19.0 Année(s) | minimum: 1.0 packet ; maximum: 2.0 packet | 1.0 Tous les jours |
Uses authorised in Canada
Source of fiber for the maintenance of healthy gastrointestinal functions. It helps to improve intestinal/bowel regularity and provides gentle relief of constipation in the general population as well as people with irritable bowel syndrome (IBS). It also helps to relieve/reduce mild gastrointestinal and abdominal discomfort/symptoms including bloating, flatulence, dyspepsia and altered bowel habits in people with IBS. Helps to improve intestinal regularity in children. Provides a gentle relief of constipation. Provides a gentle relief of constipation in children. Helps to modulate stool conditions (from either loose or hard) to normal conditions. Helps to reduce the need for laxative use. Helps reduce incidents of diarrhea. Helps to reduce glycemic response and glycemic index when taken with food.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a heath care practitioner prior to use if you are pregnant or breastfeeding, taking medications (e.g. opioids, loperamide) which inhibit peristaltic movement, have symptoms such as abdominal pain, nausea, vomiting or fever, or experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, failed to defecate following the use of a laxative product, or diabetes mellitus in which blood sugar is difficult to regulate. If symptoms worsen or if laxative effect does not occur within seven days, consult a health care practitioner.
Source
Official Health Canada record, licence 80098475
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.